Top Stories
- Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise
- Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
- Asia-Pacific markets fall as Fed inflation worries signal higher-for-longer rates; China CPI in focus
- Fed officials are worried about the inflation impacts from Trump's policies, minutes show
- Shares of California utility Edison International drop 10% as wildfires rage
